Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System [0.03%]
中枢神经系统炎症性疾病领域[18F]FDG PET/CT的最新进展
Gilles N Stormezand,J Doorduin,Andor W J M Glaudemans et al.
Gilles N Stormezand et al.
2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography (FDG-PET) is widely used to study cerebral glucose metabolism and may be useful in several inflammatory disorders of the central nervous system. Emerging literature suggests that ...
New Targets for Positron Emission Tomography Imaging in Parkinson´s Disease [0.03%]
帕金森病的正电子发射断层扫描新靶点
Yu-Jie Yang,Yi-Xin Zhao,Xin-Yi Li et al.
Yu-Jie Yang et al.
In recent years, the neuroimaging biomarkers for Parkinson's disease (PD) has advanced rapidly, targeting to the key pathological mechanisms such as α-synuclein (α-syn) aggregation, neuroinflammation, mitochondrial dysfunction and brain c...
Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective [0.03%]
纤维活化蛋白抑制剂(FAPI) PET在肉瘤中的应用：最新进展和未来展望
Roberto C Delgado Bolton,Adriana K Calapaquí Terán,Ludmila Santiago Almeida et al.
Roberto C Delgado Bolton et al.
Nuclear medicine has seen significant advancements in recent years, especially in the area of Positron Emission Tomography (PET) imaging. One of these innovations is the use of Fibroblast Activation Protein Inhibitors (FAPI) as a novel radi...
Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1 [0.03%]
靶向CXCR4和GLP-1的内分泌肿瘤PET成像研究进展
Esther Mena,Liza Lindenberg,Peter Herscovitch et al.
Esther Mena et al.
Molecular imaging has experienced significant advances in the areas of imaging probes and technology, enabling the detection of tumors at earlier stages and more accurately identifying extent of disease. To better characterize lesions, nucl...
18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment [0.03%]
18F-FDG PET在痴呆评估中的作用：共患病、新疾病及其在抗淀粉样蛋白治疗时代的角色
Tanyaluck Thientunyakit,Weerasak Muangpaisan,Satoshi Minoshima
Tanyaluck Thientunyakit
Dementia, which impairs a person's cognition and ability in daily tasks and is often caused by neurodegenerative disorders, remains one of the most challenging neuropsychiatric conditions. The prevalence of dementia has been steadily increa...
Geoffrey M Currie,K Elizabeth Hawk
Geoffrey M Currie
Artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), has significant potential to advance the capabilities of nuclear neuroimaging. The current and emerging applications of ML and DL in the processing, an...
Targets for Molecular Imaging of Neuroendocrine Tumors (NETs): An Overview and Update [0.03%]
神经内分泌肿瘤(NETs)分子影像显像靶点概览与更新
Esmail Jafari,Majid Assadi,Meysam Nasiri et al.
Esmail Jafari et al.
Neuroendocrine neoplasms (NENs) represent a diverse group of tumors originating from neuroendocrine cells, characterized by their unique biological behavior and clinical manifestations. The incidence of neuroendocrine tumors (NETs) has been...
Dirk Bender
Dirk Bender
The strength of Nuclear Medicine imaging are the compounds to be used as radioactive probes. Unfortunately there are many constraints both in relation to physiological parameters such as metabolism as well to compound related properties lik...
Katarzyna Barańska,Katarzyna Niemas,Kacper Pełka et al.
Katarzyna Barańska et al.
Central nervous system (CNS) tumors are quite rare but cause significant morbidity and mortality. Positron Emission Tomography (PET) is a widely utilized imaging modality within the field of nuclear medicine. CNS tumor diagnostics are an es...
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview [0.03%]
胃肠肿瘤18F-FAPi PET与18F-FDG PET/CT的比较：综述性文章
Zhaoguo Lin,Pawel Rasinski,Ted Nilsson et al.
Zhaoguo Lin et al.
Fibroblast activation protein (FAP) is a type II transmembrane serine protease that is highly expressed in cancer-associated fibroblasts (CAFs) but absent in quiescent fibroblasts. Its overexpression is associated with poor prognosis in var...